Wu, Y., Ho, W., Huang, Y., Jin, D.Y., Li, S., Liu, S.L., et al. (2020) SARS-CoV-2 Is an Appropriate Name for the New Coronavirus. The Lancet, 395, 949-950.
https://doi.org/10.1016/S0140-6736(20)30557-2

has been cited by the following article:

• TITLE: Diabetes Mellitus and COVID-19 at the Bouake University Hospital Center (Côte d’Ivoire)

  AUTHORS: Kone Djakaridja, Kone Famoussa, Kadiane-Oussou Juliette, Yapo Martine Tatiana, Kone Salifou, Karidioula Jean Marie, Kra Ouffoue

  KEYWORDS: Diabetes Mellitus, COVID-19, Vaccination, Bouaké, Ivory Coast

  JOURNAL NAME: Advances in Infectious Diseases, Vol.13 No.4, October 24, 2023

  ABSTRACT: Context: COVID-19 is a global public health problem and diabetes mellitus is a poor prognostic factor for the disease. The aim of this study was to investigate the epidemiological, clinical and evolutionary characteristics of COVID-19 in diabetic patients in Bouaké. Patients and Methods: This was a retrospective study carried out from January 2021 to December 2022. We included patients with diabetes known before COVID-19 infection and having a positive COVID-19 RT-PCR. Data were analyzed with Epi info7 software. Results: Among 1122 infected patients, 71 patients (6.3%) were diabetic, the sex ratio was 1.3 and the mean age was 58.7 years. Type 2 diabetes (97.2%) was predominant and the average seniority was 3.1 years. Arterial hypertension (46.5%) was the main comorbidity. The main clinical signs were cough (69%), dyspnea (43.7%) and fever (23.9%). Oxygen saturation was Conclusion: Diabetes mellitus remains one of the most important comorbidities of severe Covid-19. The death rate of diabetics was high. Hence the need to vaccinate people living with diabetes.